???global.info.a_carregar???
Rui Adão. Completed the Mestrado integrado in Fisiopatologia Cardiovascular in 2013 by Universidade do Porto Faculdade de Medicina, Doutoramento in Ciências Cardiovasculares in 2019/01/28 by Universidade do Porto Faculdade de Medicina and Licenciatura in Biologia in 2011 by Universidade de Aveiro. Is Researcher in Universidade do Porto Unidade de Investigação e Desenvolvimento Cardiovascular and Marie Sklodowska-Curie Postdoctoral Fellow at Department of Pharmacology and Toxicology in Universidad Complutense de Madrid Facultad de Medicina. Published 36 articles in journals. Has 1 book(s). Organized 3 event(s). Participated in 82 event(s). Has received 23 awards and/or honors. Participates and/or participated as Post-doc Fellow in 1 project(s), Principal investigator in 1 project(s) and Researcher in 11 project(s). Works in the area(s) of Medical and Health Sciences with emphasis on Basic Medicine with emphasis on Physiology. In his curriculum Ciência Vitae the most frequent terms in the context of scientific, technological and artistic-cultural output are: Ciências médicas e da saúde; Medical and Health sciences; Ciências da saúde; Health sciences; Ciências médicas e da saúde::Ciências da saúde; Medical and Health sciences::Health sciences; basic research; cardiovascular system; .
Ler resumo completo ↓
Identificação

Identificação pessoal

Nome completo
Rui Adão
Género
Masculino

Nomes de citação

  • Adão, Rui

Identificadores de autor

Ciência ID
E11C-E68E-8232
ORCID iD
0000-0003-2203-436X
Google Scholar ID
https://scholar.google.com/citations?user=u0a2ch4AAAAJ

Endereços de correio eletrónico

  • ruiadao@med.up.pt (Profissional)
  • ruimigueladao@gmail.com (Pessoal)

Moradas

  • Faculdade de Medicina da Universidade do Porto - Dp. de Cirurgia e Fisiologia . Rua Professor Hernâni Monteiro , 4200-319, Porto, Porto, Portugal (Profissional)

Domínios de atuação

  • Ciências Médicas e da Saúde - Medicina Básica - Fisiologia

Idiomas

Idioma Conversação Leitura Escrita Compreensão Peer-review
Inglês Utilizador proficiente (C1) Utilizador proficiente (C1) Utilizador proficiente (C1) Utilizador proficiente (C1)
Português Utilizador proficiente (C1) Utilizador proficiente (C1) Utilizador proficiente (C1) Utilizador proficiente (C1)
Espanhol; Castelhano Utilizador elementar (A1) Utilizador elementar (A1) Utilizador elementar (A1) Utilizador elementar (A1)
Formação
Grau Classificação
2019/01/28
Concluído
 Ciências Cardiovasculares (Doutoramento)
Universidade do Porto Faculdade de Medicina, Portugal
"“Pathophysiological role of urocortin-2 system in pulmonary hypertension – therapeutic implications”" (TESE/DISSERTAÇÃO)
 Aprovado
2019 - 2019
Concluído
 Federation of European Laboratory Animal Science Associations (FELASA Functions A, B and D) accreditation course (Outros)
Universidade do Porto Instituto de Investigação e Inovação em Saúde, Portugal
2013
Concluído
 Fisiopatologia Cardiovascular (Mestrado integrado)
Universidade do Porto Faculdade de Medicina, Portugal
""Evaluation of intrinsic myocardial properties in pulmonary hypertension - modulation by neuregulin 1"" (TESE/DISSERTAÇÃO)
 19
2012 - 2012
Concluído
 Pedagogical Aptitude training course - IEFP certified trainer (CCP) (Outros)
Centro de Formaçao Comenius, Portugal
2011
Concluído
 Biologia (Licenciatura)
Universidade de Aveiro, Portugal
""Hipertensão Pulmonar e Insuficiência cardíaca - mecanismos fisiopatológicos e regulação neurohumoral"" (TESE/DISSERTAÇÃO)
 17
Percurso profissional

Ciência

Categoria Profissional
Instituição de acolhimento 		Empregador
2022 - Atual Investigador (Investigação) Universidade do Porto Unidade de Investigação e Desenvolvimento Cardiovascular, Portugal
2019/07/01 - 2022 Pós-doutorado (Investigação) Universidade do Porto Unidade de Investigação e Desenvolvimento Cardiovascular, Portugal
2019/09/01 - 2019/12/31 Investigador visitante (Investigação) Medizinische Universität Graz Zentrum für Physiologische Medizin, Áustria
2017/09/01 - 2017/12/21 Investigador visitante (Investigação) Medizinische Universität Graz Zentrum für Physiologische Medizin, Áustria

Outros

Categoria Profissional
Instituição de acolhimento 		Empregador
2022 - Atual Marie Sklodowska-Curie Postdoctoral Fellow at Department of Pharmacology and Toxicology Universidad Complutense de Madrid Facultad de Medicina, Espanha
2014/08/01 - 2019/01/28 FCT PhD scholarship; Project: "Pathophysiological role of urocortin-2 system in pulmonary hypertension – therapeutic implications"; Ref: SFRH/BD/96403/2013 Universidade do Porto Unidade de Investigação e Desenvolvimento Cardiovascular, Portugal
2013/08/01 - 2014/07/31 FCT Master Scholarship; Project: “Papel fisiopatológico e potencial terapêutico da urocortina 2 na hipertensão pulmonar”, Ref: PTDC/DTP-FTO/0130/2012 Universidade do Porto Unidade de Investigação e Desenvolvimento Cardiovascular, Portugal
2010/09/13 - 2011/07/18 Curricular Internship; Advisor: Prof Carmen Brás Silva; Final grade: 20 Universidade do Porto Unidade de Investigação e Desenvolvimento Cardiovascular, Portugal
2009/09/21 - 2010/07/06 Curricular Internship; Molecular Biology techniques; Advisor: Prof. Doutor Manuel Santos; Final grade: 17 valores Universidade de Aveiro Departamento de Biologia, Portugal
2009/05/04 - 2010/05/04 Research Integration scholarship; Advisor: Prof Eduardo Silva; Project: Lead availability in soils from Portugal's Centre Region with special reference to bioaccessibility" Universidade de Aveiro Departamento de Geociências, Portugal
Projetos

Bolsa

Designação Financiadores
2023/03 - Atual Relaxin-2 and Pulmonary Arterial Hypertension: pathophysiological role and therapeutic potential
2022.08921.PTDC
Investigador responsável
Universidade do Porto Unidade de Investigação e Desenvolvimento Cardiovascular, Portugal
Em curso
2022/10 - Atual Modulation of potassium channels for pulmonary artery hypertension
--
Bolseiro de Pós-Doutoramento
Universidad Complutense de Madrid Facultad de Medicina, Espanha
Em curso
2019 - Atual ERA-CVD-funded project MINOTAUR- Metabolic Therapy for Diastolic Heart Failure
--
Investigador
2018 - Atual IMPAcT - Insight in the pathophysiological role of Mir-146a in Pulmonary Arterial Hypertension
PTDC/MED-FSL/31719/2017
Investigador
Associação para a Inovação e Desenvolvimento da FCT
2017/02/01 - Atual Effect of GGF2 on pulmonary artery banding-induced right ventricle hypertrophy - Collaboration with ACORDA Pharmaceutics
..
Investigador
2017 - Atual Loss of KCNK3 is a hallmark of RV hypertrophy/dysfunction associated with pulmonary hypertension
-
Investigador
2016 - Atual Bmpr2 Mutant Rats Develop Pulmonary and Cardiac Characteristics of Pulmonary Arterial Hypertension
-
Investigador
2015/01/01 - Atual Efficacy of the thromboxane receptor antagonist NTP42 in experimental pulmonary arterial hypertension - Collaboration with ATXA Pharmaceutics
--
Investigador
Concluído
2017 - 2020 ß-3 adrenoceptors- a therapeutic target for pulmonary arterial hypertension
-
Investigador
2013/07 - 2018/10 Pathophysiological role and therapeutic potential of urocortin 2 in pulmonary hypertension
grant.Provided by PTCRIS: 124203
Investigador
2014 - 2017 Left intraventricular diastolic and systolic pressure gradients in human heart failure
-
Investigador
2012 - 2017 Role of the neuregulin system in pulmonary arterial hypertension
PTDC/SAU-FCF/100442/2008
Investigador
2008 - 2010 Lead availability in soils from Portugal's Centre Region with special reference to bioaccessibility
-
Investigador
Universidade de Aveiro Departamento de Geociências, Portugal

Projeto

Designação Financiadores
2021/01/01 - 2025/12/31 Rede de Investigação em Saúde: do Laboratório à Saúde Comunitária
LA/P/0053/2020
10.54499/LA/P/0053/2020
Universidade do Porto Unidade de Investigação e Desenvolvimento Cardiovascular, Portugal

Instituto Português de Oncologia do Porto Francisco Gentil EPE, Portugal

Universidade do Algarve, Portugal

Universidade do Porto Instituto de Ciências Biomédicas Abel Salazar, Portugal

Universidade do Porto Faculdade de Ciências, Portugal

Universidade da Madeira, Portugal

Universidade Nova de Lisboa, Portugal

Instituto Português de Oncologia do Porto Francisco Gentil Centro de Investigação, Portugal

Universidade de Lisboa Centro Cardiovascular da Universidade de Lisboa, Portugal

Universidade de Aveiro, Portugal

Centro de Investigação em Tecnologias e Serviços de Saúde, Portugal

Associação para a Investigação e Desenvolvimento da Faculdade de Medicina, Portugal

Escola Superior de Enfermagem do Porto, Portugal

Universidade do Porto Faculdade de Medicina, Portugal
Fundação para a Ciência e a Tecnologia
Em curso
2021/01/01 - 2025/12/31 Health Research Network: From Lab to Community Health
LA/P/0053/2020
10.54499/LA/P/0053/2020
Universidade do Porto Unidade de Investigação e Desenvolvimento Cardiovascular, Portugal

Instituto Português de Oncologia do Porto Francisco Gentil EPE, Portugal

Universidade do Algarve, Portugal

Universidade do Porto Instituto de Ciências Biomédicas Abel Salazar, Portugal

Universidade do Porto Faculdade de Ciências, Portugal

Universidade da Madeira, Portugal

Universidade Nova de Lisboa, Portugal

Instituto Português de Oncologia do Porto Francisco Gentil Centro de Investigação, Portugal

Universidade de Lisboa Centro Cardiovascular da Universidade de Lisboa, Portugal

Universidade de Aveiro, Portugal

Centro de Investigação em Tecnologias e Serviços de Saúde, Portugal

Associação para a Investigação e Desenvolvimento da Faculdade de Medicina, Portugal

Escola Superior de Enfermagem do Porto, Portugal

Universidade do Porto Faculdade de Medicina, Portugal
Fundação para a Ciência e a Tecnologia
Em curso
Produções

Publicações

Artigo em conferência
  1. Adão, Rui; Bras-Silva, C. Autor correspondente: Bras-Silva, C. "Adão R, Conceição G, Miranda Silva D, Miranda S, Pimentel LD, Vaz Salvador P, Maia Rocha C, Mendes Ferreira P, Lourenço AP, Falcão Pires I, Leite-Moreira A, Brás Silva C. Role of urocortin-2 in heart failure with preserved ejection fraction. Rev Port Cardiol. 2020;39(Espec Congr): 23.". Trabalho apresentado em CPC 2021- Congresso Português de Cardiologia 2020 /Portuguese Congress of Cardiology 2020, 2020.
  2. Bras-Silva, C; Adão, Rui. Autor correspondente: Bras-Silva, C. "Vaz-Salvador P, Adão R, Conceição G, Miranda-Silva D, Miranda S, Pimentel D, Maia-Rocha C, Mendes-Ferreira P, Lourenço AP, Falcão-Pires I, Leite-Moreira AF, Brás-Silva C. The role of Urocortin-2 in Heart Failure with Preserved Ejection Fraction. Porto Biomed J. 2021; 6:1:36.". Trabalho apresentado em Yes Meeting 2020, 2020.
  3. PINTALHÃO, MARIANA; Maia-Rocha C; Martins clara Rafael; Adão, Rui; António barros; ADELINO LEITE-MOREIRA; Paulo Bettencourt; Paulo Castro Chaves; Brás-Silva, Carmen. "Serum Urocortin-2 is Associated With Volume Overload and Pulmonary Hypertension in Acute Heart Failure". Trabalho apresentado em AHA Scientific Sessions 2018, Chicago, 2018.
    Publicado
  4. Ferreira, Pedro; Adão, Rui; Rocha, Carolina; Cerqueira, Rui; Pires, Inês; Chaves, Paulo; Keulenaer, Gilles; Moreira, Adelino; Silva, Carmen Brás. "Efeitos terapêuticos da neuregulina-1 num modelo experimental de hipertensão pulmonar". 2013.
Artigo em revista
  1. Mírian Quintão Assis; Luciano Bernardes Leite; Luiz Otávio Guimarães-Ervilha; Rui Adão; Emily Correna Carlo Reis; Antônio José Natali; Mariana Machado-Neves. "Pulmonary Arterial Hypertension-Induced Reproductive Damage: Effects of Combined Physical Training on Testicular and Epididymal Parameters in Rats". Biomedicines (2025): https://doi.org/10.3390/biomedicines13020410.
    10.3390/biomedicines13020410
  2. Rui Adão; Bianca Barreira; Elena Paternoster; Daniel Morales-Cano; Miguel A. Olivencia; Begoña Quintana-Villamandos; Diego A. Rodriguez-Chiaradía; Angel Cogolludo; Francisco Perez-Vizcaino. "Vitamin D as an add-on therapy to phosphodiesterase-5 inhibitor in experimental pulmonary arterial hypertension". American Journal of Physiology-Lung Cellular and Molecular Physiology (2025): https://doi.org/10.1152/ajplung.00319.2024.
    10.1152/ajplung.00319.2024
  3. Nísia Almeida-Pinto; Thomas Bernd Dschietzig; Carmen Brás-Silva; Rui Adão. "Cardiovascular effects of relaxin-2: therapeutic potential and future perspectives". Clinical Research in Cardiology (2024): https://doi.org/10.1007/s00392-023-02305-1.
    10.1007/s00392-023-02305-1
  4. Inês Vasconcelos; Madalena von Hafe; Rui Adão; Adelino Leite-Moreira; Carmen Brás-Silva. "Corticotropin-releasing hormone and obesity: From fetal life to adulthood". Obesity Reviews (2024): https://doi.org/10.1111/obr.13763.
    10.1111/obr.13763
  5. Joana Santos-Gomes; Pedro Mendes-Ferreira; Rui Adão; Carolina Maia-Rocha; Beatriz Rego; Manu Poels; Anaïs Saint-Martin Willer; et al. "Unraveling the Impact of miR-146a in Pulmonary Arterial Hypertension Pathophysiology and Right Ventricular Function". International Journal of Molecular Sciences (2024): https://doi.org/10.3390/ijms25158054.
    10.3390/ijms25158054
  6. André Balsa; Rui Adão; Carmen Brás-Silva. "Therapeutic Approaches in Pulmonary Arterial Hypertension with Beneficial Effects on Right Ventricular Function—Preclinical Studies". International Journal of Molecular Sciences (2023): https://doi.org/10.3390/ijms242115539.
    10.3390/ijms242115539
  7. Adão, Rui; Kraler SC; Abdellatif, Mahmoud; Ljubojevic-Holzer; Adelino F. Leite-Moreira; Simon Sedej; Brás-Silva, Carmen. "Acute and chronic effects of urocortin-2 therapy on intracellular calcium homeostasis in right heart failure induced by pulmonary arterial hypertension". Scientific Reports (2023):
    Em revisão
  8. Pedro Mendes-Ferreira; Adão, Rui; Alice Miranda; Adelino F. Leite-Moreira; Carmen Brás Silva. "Comprehensive cardiovascular function analysis in rodents with right heart failure". Journal of Visualized Experiments (2023):
    Em revisão
  9. Anaïs Saint-Martin Willer; Joana Santos-Gomes; Rui Adão; Carmen Brás-Silva; Mélanie Eyries; Francisco Pérez-Vizcaino; Véronique Capuano; David Montani; Fabrice Antigny. "Physiological and pathophysiological roles of the KCNK3 potassium channel in the pulmonary circulation and the heart". The Journal of Physiology (2023): https://doi.org/10.1113/JP284936.
    10.1113/JP284936
  10. Miguel A. Olivencia; Marta Villegas-Esguevillas; Maria Sancho; Bianca Barreira; Elena Paternoster; Rui Adão; María Jesús Larriba; Angel Cogolludo; Francisco Perez-Vizcaino. "Vitamin D Receptor Deficiency Upregulates Pulmonary Artery Kv7 Channel Activity". International Journal of Molecular Sciences (2023): https://doi.org/10.3390/ijms241512350.
    10.3390/ijms241512350
  11. Saint-Martin Willer, Anaïs; Joana Santos-Gomes; Adão, Rui; Brás-Silva, Carmen; Eyries, Mélanie; Pérez-Vizcaino, Francisco; Capuano, Véronique; Montani, David; Antigny, Fabrice. "Physiological and pathophysiological roles of the KCNK3 potassium channel in the pulmonary circulation and the heart". The Journal of Physiology 601 17 (2023): 3717-3737. http://dx.doi.org/10.1113/jp284936.
    Publicado • 10.1113/jp284936
  12. Eamon P. Mulvaney; Fabiana Renzo; Rui Adão; Emilie Dupre; Lucia Bialesova; Viviana Salvatore; Helen M. Reid; et al. "The thromboxane receptor antagonist NTP42 promotes beneficial adaptation and preserves cardiac function in experimental models of right heart overload". Frontiers in Cardiovascular Medicine 9 (2022): http://dx.doi.org/10.3389/fcvm.2022.1063967.
    10.3389/fcvm.2022.1063967
  13. Rita Figueiredo; Rui Adão; Adelino F. Leite-Moreira; Jennifer Mâncio; Carmen Brás-Silva. "Candidate microRNAs as prognostic biomarkers in heart failure: A systematic review". Revista Portuguesa de Cardiologia 41 10 (2022): 865-885. http://dx.doi.org/10.1016/j.repc.2021.03.020.
    10.1016/j.repc.2021.03.020
  14. Rui Adão; Bart Bijnens. "At the heart of artificial intelligence: the future might well be based on synthetic cells". Cardiovascular Research (2022): https://doi.org/10.1093/cvr/cvac129.
    10.1093/cvr/cvac129
  15. Joana Santos-Gomes; Inês Gandra; Rui Adão; Frédéric Perros; Carmen Brás-Silva. "An Overview of Circulating Pulmonary Arterial Hypertension Biomarkers". Frontiers in Cardiovascular Medicine 9 (2022): http://dx.doi.org/10.3389/fcvm.2022.924873.
    10.3389/fcvm.2022.924873
  16. Gomes, Joana; Ferreira, Pedro; Adão, Rui; Rocha, Carolina; Vasconcelos, Inês; Rego, Beatriz; Vaz-Salvador, Pedro; Moreira, Adelino; Silva, Carmén. "THERAPEUTIC EFFECTS OF NEBULIZATION- BASED DELIVERY OF ANTI-MIR-146A IN EXPERIMENTAL PULMONARY ARTERIAL HYPERTENSION". Journal of Hypertension 40 Suppl 1 (2022): e37-e38. http://dx.doi.org/10.1097/01.hjh.0000835592.72344.ff.
    10.1097/01.hjh.0000835592.72344.ff
  17. Rúben Almeida-Pinto; Adelino F. Leite-Moreira; Carmen Brás-Silva; Rui Adão. "Pulmonary Valve Replacement: A New Paradigm with Tissue Engineering". Current Problems in Cardiology (2022): 101212-101212. https://doi.org/10.1016/j.cpcardiol.2022.101212.
    10.1016/j.cpcardiol.2022.101212
  18. Joana Gomes; Hélène Le Ribeuz; Bras-Silva C; Fabrice Antigny; Adão R. "Role of Ion Channel Remodeling in Endothelial Dysfunction Induced by Pulmonary Arterial Hypertension". Biomolecules (2022): https://www.mdpi.com/2218-273X/12/4/484.
    10.3390/biom12040484
  19. Pedro Vaz-Salvador; Rui Adão; Inês Vasconcelos; Adelino F. Leite-Moreira; Carmen Brás-Silva. "Heart Failure with Preserved Ejection Fraction: a Pharmacotherapeutic Update". Cardiovascular Drugs and Therapy (2022): https://doi.org/10.1007/s10557-021-07306-8.
    10.1007/s10557-021-07306-8
  20. Inês Vasconcelos; Rui Adão; Miriam T. Rademaker; Adelino F. Leite-Moreira; Ana Patrícia Fontes-Sousa; Carmen Brás-Silva. "Urocortins as biomarkers in cardiovascular disease". Clinical Science (2022): https://doi.org/10.1042/CS20210732.
    10.1042/CS20210732
  21. Adão R; Archer SL. "Corrigendum to: Scientist on the spot: Exploring the cause and cure for pulmonary arterial hypertension.". Cardiovascular research (2021): http://europepmc.org/abstract/med/34143877.
    10.1093/cvr/cvab191
  22. Rui Adão; Stephen L Archer. "Scientist on the Spot: Exploring the cause and cure for pulmonary arterial hypertension". Cardiovascular Research 117 6 (2021): e82-e83. https://doi.org/10.1093/cvr/cvab091.
    10.1093/cvr/cvab091
  23. Rui Adão; Paul R Stoddart; Karlheinz Peter. "Avalanching nanoparticles bring new light to cardiovascular imaging". Cardiovascular Research 117 5 (2021): e60-e63. https://doi.org/10.1093/cvr/cvab092.
    10.1093/cvr/cvab092
  24. Pintalhao M; Maia-Rocha C; Castro-Chaves P; Adão R; Barros AS; Clara Martins R; Leite-Moreira A; Bettencourt P; Bras-Silva C. "Urocortin-2 in Acute Heart Failure: Role as a Marker of Volume Overload and Pulmonary Hypertension.". Current problems in cardiology (2021): http://europepmc.org/abstract/med/33994037.
    10.1016/j.cpcardiol.2021.100860
  25. Vaz-Salvador, Pedro; Adão, Rui; Conceição, Glória; Silva, Daniela; Miranda, Sónia; Pimentel, Luís; Rocha, Carolina; et al. "15th YES Meeting – Abstracts". Porto Biomedical Journal 6 1 (2021): e100. http://dx.doi.org/10.1097/j.pbj.0000000000000100.
    Publicado • 10.1097/j.pbj.0000000000000100
  26. Abdellatif M; Trummer-Herbst V; Koser F; Durand S; Adão R; Vasques-Nóvoa F; Freundt JK; et al. "Nicotinamide for the treatment of heart failure with preserved ejection fraction.". Science translational medicine (2021): http://europepmc.org/abstract/med/33568522.
    10.1126/scitranslmed.abd7064
  27. Rui Adão; Hafid Ait-Oufella. "Scientists on the Spot: Inflammation in atherosclerosis". Cardiovascular Research 117 1 (2021): e7-e8. https://doi.org/10.1093/cvr/cvaa314.
    10.1093/cvr/cvaa314
  28. Lambert M; Mendes-Ferreira P; Ghigna MR; LeRibeuz H; Adão R; Boet A; Capuano V; et al. "Kcnk3 Dysfunction Exaggerates The Development Of Pulmonary Hypertension Induced By Left Ventricular Pressure Overload.". Cardiovascular research (2021): http://europepmc.org/abstract/med/33483721.
    10.1093/cvr/cvab016
  29. Adão R; Marian AJ. "Highlights of American Heart Association Scientific Sessions 2020: a virtual experience.". Cardiovascular research (2021): http://europepmc.org/abstract/med/33426562.
    10.1093/cvr/cvaa346
  30. Mulvaney EP; Reid HM; Bialesova L; Mendes-Ferreira P; Adão R; Brás-Silva C; Kinsella BT. "Efficacy of the thromboxane receptor antagonist NTP42 alone, or in combination with sildenafil, in the sugen/hypoxia-induced model of pulmonary arterial hypertension.". European journal of pharmacology (2020): http://europepmc.org/abstract/med/33121950.
    10.1016/j.ejphar.2020.173658
  31. Leite-Moreira AF; Adão R. "Mobile cardiology during the COVID-19 outbreak.". Cardiovascular research (2020): http://europepmc.org/abstract/med/32980878.
    10.1093/cvr/cvaa270
  32. Martinho S; Adão R; Leite-Moreira AF; Brás-Silva C; Sofia Martinho; Adão, Rui; Adelino F. Leite-Moreira; Carmen Brás-Silva. "Persistent Pulmonary Hypertension of the Newborn: Pathophysiological Mechanisms and Novel Therapeutic Approaches.". Frontiers in pediatrics (2020): http://europepmc.org/abstract/med/32850518.
    Submetido • 10.3389/fped.2020.00342
  33. Adão, Rui. "Inside the heart of COVID-19.". Cardiovascular research (2020): https://doi.org/10.1093/cvr/cvaa086.
    10.1093/cvr/cvaa086
  34. Mulvaney, Eamon; Reid, Helen M.; Bialesova, Lucia; Mendes-Ferreira, Pedro; Adão, Rui; Brás-Silva, Carmen; Kinsella, B. Therese. "Efficacy of the thromboxane receptor antagonist NTP42 alone, or in combination with Sildenafil, in the Sugen/hypoxia-induced model of NTP42". European Journal of Pharmacology (2020):
    Submetido
  35. Rui Adão; Pedro Mendes-Ferreira; Carolina Maia-Rocha; Diana Santos-Ribeiro; Patrícia Gonçalves Rodrigues; André Vidal-Meireles; Cláudia Monteiro-Pinto; et al. "Neuregulin-1 attenuates right ventricular diastolic stiffness in experimental pulmonary hypertension". Clinical and Experimental Pharmacology and Physiology (2019): https://doi.org/10.1111/1440-1681.13043.
    10.1111/1440-1681.13043
  36. Ramjug, S.; Adão, R.; Lewis, R.; Coste, F.; De Man, F.; Jimenez, D.; Sitbon, O.; Delcroix, M.; Vonk-Noordegraaf, A.. "Highlights from the ERS international congress 2018: Assembly 13 - pulmonary vascular diseases". ERS Monograph 5 1 (2019): http://www.scopus.com/inward/record.url?eid=2-s2.0-85067942271&partnerID=MN8TOARS.
    10.1183/23120541.00202-2018
  37. Hautefort, A.; Mendes-Ferreira, P.; Sabourin, J.; Manaud, G.; Bertero, T.; Rucker-Martin, C.; Riou, M.; et al. "Bmpr2 Mutant Rats Develop Pulmonary and Cardiac Characteristics of Pulmonary Arterial Hypertension". Circulation 139 7 (2019): 932-948. http://www.scopus.com/inward/record.url?eid=2-s2.0-85058621612&partnerID=MN8TOARS.
    10.1161/CIRCULATIONAHA.118.033744
  38. Monteiro-Pinto, C.; Adão, R.; Leite-Moreira, A.F.; Brás-Silva, C.. "Cardiovascular Effects of Urocortin-2: Pathophysiological Mechanisms and Therapeutic Potential". Cardiovascular Drugs and Therapy 33 5 (2019): 599-613. http://www.scopus.com/inward/record.url?eid=2-s2.0-85073934389&partnerID=MN8TOARS.
    10.1007/s10557-019-06895-9
  39. Adão, Rui; Kraler, Simon; Abdellatif, Mahmoud; Pinto, Ana Rita; Mendes-Ferreira, Pedro; Ljubojevic-Holzer, S; Leite-Moreira, Adelino; Sedej, Simon; Brás-Silva, Carmen. "Acute and chronic effects of urocortin-2 therapy on intracellular Ca2+ homeostasis in right heart failure induced by pulmonary arterial hypertension". Scientific Reports (2019):
    Em revisão
  40. Corremans R; Adão R; De Keulenaer GW; Leite-Moreira AF; Brás-Silva C. "Update on pathophysiology and preventive strategies of anthracycline-induced cardiotoxicity.". Clinical and experimental pharmacology & physiology (2018): http://europepmc.org/abstract/med/30244497.
    10.1111/1440-1681.13036
  41. Adão, R.; Mendes-Ferreira, P.; Santos-Ribeiro, D.; Maia-Rocha, C.; Pimentel, L.D.; Monteiro-Pinto, C.; Mulvaney, E.P.; et al. "Urocortin-2 improves right ventricular function and attenuates pulmonary arterial hypertension". Cardiovascular Research 114 8 (2018): 1165-1177. http://www.scopus.com/inward/record.url?eid=2-s2.0-85050947222&partnerID=MN8TOARS.
    10.1093/cvr/cvy076
  42. Lambert, M.; Boet, A.; Rucker-Martin, C.; Mendes-Ferreira, P.; Capuano, V.; Hatem, S.; Adão, R.; et al. "Loss of KCNK3 is a hallmark of RV hypertrophy/dysfunction associated with pulmonary hypertension". Cardiovascular Research 114 6 (2018): 880-893. http://www.scopus.com/inward/record.url?eid=2-s2.0-85045412406&partnerID=MN8TOARS.
    10.1093/cvr/cvy016
  43. Guerra M; Mendes-Ferreira P; Adão R; Pereira E; Vieira M; Lourenço AP; Brás-Silva C; et al. "Improvement in left intraventricular pressure gradients after aortic valve replacement in aortic stenosis patients.". Experimental physiology 102 4 (2017): 411-421. http://europepmc.org/abstract/med/28194824.
    10.1113/ep086191
  44. Santos-Ribeiro D; Mendes-Ferreira P; Maia-Rocha C; Adão R; Leite-Moreira AF; Brás-Silva C. "Pulmonary arterial hypertension: Basic knowledge for clinicians.". Archives of cardiovascular diseases (2016): http://europepmc.org/abstract/med/27595464.
    10.1016/j.acvd.2016.03.004
  45. Mendes-Ferreira P; Santos-Ribeiro D; Adão R; Maia-Rocha C; Mendes-Ferreira M; Sousa-Mendes C; Leite-Moreira AF; Brás-Silva C. "Distinct right ventricle remodeling in response to pressure overload in the rat.". American Journal of Physiology - Heart and Circulatory Physiology (2016): http://europepmc.org/abstract/med/27199115.
    10.1152/ajpheart.00089.2016
  46. Mendes-Ferreira P; Maia-Rocha C; Adão R; Mendes MJ; Santos-Ribeiro D; Alves BS; Cerqueira RJ; et al. "Neuregulin-1 improves right ventricular function and attenuates experimental pulmonary arterial hypertension.". Cardiovascular research (2016): http://europepmc.org/abstract/med/26503987.
    10.1093/cvr/cvv244
  47. Adão R; Santos-Ribeiro D; Rademaker MT; Leite-Moreira AF; Brás-Silva C. "Urocortin 2 in cardiovascular health and disease.". (2015): http://europepmc.org/abstract/med/25748088.
    10.1016/j.drudis.2015.02.012
  48. Adão R; de Keulenaer G; Leite-Moreira A; Brás-Silva C. "Cardiotoxicity associated with cancer therapy: pathophysiology and prevention strategies.". (2013): http://europepmc.org/abstract/med/23623503.
    10.1016/j.repc.2012.11.002
  49. Patinha C; Reis AP; Dias C; Cachada A; Adão R; Martins H; Ferreira da Silva E; Sousa AJ. "Lead availability in soils from Portugal's Centre Region with special reference to bioaccessibility.". (2012): http://europepmc.org/abstract/med/21989856.
    10.1007/s10653-011-9431-1
Livro
  1. Adão, R.; Maia-Rocha, C.; Santos-Ribeiro, D.; Mendes-Ferreira, P.; Leite-Moreira, A.F.; Brás-Silva, C.. Cardiotoxicity of cancer chemotherapy–Recent developments. 2016.
    10.2174/9781681081656116070004
Poster em conferência
  1. Moreira-Costa, Liliana; Leite-Moreira, André; Adão, Rui; Miranda, Isabel; Cerqueira, RJ; Perros, Frédéric; ADELINO F. LEITE-MOREIRA; Lourenço, André; Mendes-Ferreira, Pedro. "Indução de um modelo de hipertensão pulmonar crónica em suínos pela embolização de suturas". Trabalho apresentado em 39th Pneumology Congress, 2023.
  2. Moreira-Costa, Liliana; Leite-Moreira, André; Adão, Rui; Miranda, Isabel; Rui Cerqueira; Perros, Frédéric; ADELINO F. LEITE-MOREIRA; Lourenco, AP; Mendes-Ferreira, Pedro. "Size does matter: a simple swine model of chronic pulmonary hypertension". Trabalho apresentado em European Respiratory Society International Congress, 2023.
  3. Joana Santos-Gomes; Pedro Mendes-Ferreira; Adão, Rui; Carolina Maia-Rocha; Inês Vasconcelos; Adelino Leite-Moreira; Brás-Silva, Carmen. "Therapeutic effects of nebulization- based delivery of anti-miR-146a in experimental pulmonary arterial hypertension". Trabalho apresentado em Congresso Português de Cardiologia 2022, 2022.
  4. Inês Vasconcelos; Adão, Rui; Pedro Vaz-Salvador; Glória Conceição; Daniela Miranda-Silva; Joana Santos-Gomes; Beatriz Rego; et al. "Therapeutic effect of Urocortin-2 in Heart Failure with Preserved Ejection Fraction". Trabalho apresentado em Portuguese Congress of Cardiology, 2022.
  5. Inês Vasconcelos; Pedro Vaz-Salvador; Adão, Rui; Glória Conceição; Daniela Miranda-Silva; Joana Santos-Gomes; Beatriz Rego; et al. "The role of Urocortin-2 in Heart Failure with Preserved Ejection Fraction.". Trabalho apresentado em VI Jornadas de Bioquímica, 2021.
  6. Vilas-Boas, Inês; Castro, Catarina; Adão, Rui; Brás-Silva, Carmen; Cruz, Catarina; Ferreira, Susana Maria de Sousa da Silva. "Does Urocortin-2 induce changes in neurogenesis of the hippocampal formation of rats with Heart Failure with preserved Ejection Fraction?". Trabalho apresentado em IJUP - Young Research Meeting, 2020.
Resumo em conferência
  1. Joana Santos-Gomes; Pedro Mendes-Ferreira; Adão, Rui; Carolina Maia-Rocha; Inês Vasconcelos; Adelino Leite-Moreira; Brás-Silva, Carmen. "The role of miR-146a in the pathophysiology of pulmonary arterial hypertension - Therapeutic implications". Trabalho apresentado em Heart Failure Congress, Madrid, 2022.
    Publicado
  2. Ines Vasconcelos; Pedro Vaz-Salvador; Adão, Rui; Glória Conceição; Daniela Miranda-Silva; Joana Santos-Gomes; Beatriz Rego; et al. "Pathophysiological and therapeutic implications of Urocortin-2 in Heart Failure with Preserved Ejection Fraction.". Trabalho apresentado em YES meeting 16th edition – Young European Scientist Meeting, Porto, 2021.
    Publicado
  3. Beatriz Rego; Pedro Mendes-Ferreira; Adão, Rui; Carolina Maia-Rocha; Joana Santos-Gomes; Ines Vasconcelos; Ines Gandra; et al. "The role of miR-146a in the pathophysiology of pulmonary arterial hypertension.". Trabalho apresentado em YES meeting 16th Edition – Young European Scientist Meeting, Porto, 2021.
    Publicado
  4. Adão, Rui; Glória Conceição; Daniela Silva Miranda; Luís D. Pimentel; Pedro Vaz Salvador; Carolina Maia-Rocha; Pedro Mendes-Ferreira; et al. "Role of urocortin-2 in heart failure with preserved ejection fraction". Trabalho apresentado em Portuguese Society of Cardiology Meeting, 2020.
    Publicado
  5. Miranda, Sónia; Mendes-Ferreira, Pedro; Adão, Rui; Maia-Rocha, Carolina; Santos-Ribeiro, Diana; Pimentel, Luís; Monteiro-Pinto, Cláudia; et al. "MicroRNA-146a role in the pathophysiology of Pulmonary Arterial Hypertension". Trabalho apresentado em SPCCTV Congress, 2019.
    Publicado
  6. Mendes-Ferreira, Pedro; Adão, Rui; Leite-Moreira, Adelino; Brás-Silva, Carmen; Belge, Catharina. "ß-3 adrenoceptors: a therapeutic target for Pulmonary Arterial Hypertension". Trabalho apresentado em SPCCTV Congress, 2019.
    Publicado
  7. Adão, Rui. "Effects of urocortin-2 on cellular Ca2+ homeostasis in right heart failure induced by pulmonary artery hypertension". Trabalho apresentado em Eur Respir J, 2018.
    Publicado
  8. Adão, Rui. "Urocortin-2 improves right ventricular function and attenuates pulmonary arterial hypertension". Trabalho apresentado em Eur Respir J, 2018.
    Publicado
  9. Adão, Rui. "Urocortin-2 improves right ventricular function and attenuates experimental pulmonary arterial hypertension". Trabalho apresentado em Cardiovascular Research, 2016.
    Publicado
  10. Adão, Rui. "The right ventricle molecular changes associated with pulmonary arterial hypertension are attenuated by Urocortin 2 treatment". Trabalho apresentado em European heart journal, 2016.
  11. Adão, Rui. "Molecular mechanisms underlying the beneficial effects of Urocortin 2 in pulmonary arterial hypertension". Trabalho apresentado em Cardiovascular Research, 2016.
    Publicado
  12. Adão, Rui. "The right ventricle molecular changes associated with pulmonary arterial hypertension are attenuated by Urocortin-2 treatment". Trabalho apresentado em European Journal of Heart Failure, 2016.
  13. Adão, Rui. "Urocortin-2 treatment reduces right ventricular dysfunction in pulmonary arterial hypertension". Trabalho apresentado em European heart journal, 2016.
    Publicado
  14. Adão, Rui. "Urocortin-2 Improves Right Ventricular Function In Pulmonary Arterial Hypertension". Trabalho apresentado em American journal of respiratory and critical care medicine, 2016.
  15. Adão, Rui. "Microrna-146a Expression Is Increased In Human Pah". Trabalho apresentado em American journal of respiratory and critical care medicine, 2016.
    Publicado
  16. Adão, Rui. "Pulmonary artery banding-induced adaptive and maladaptive remodelling of the right ventricle in the rat". Trabalho apresentado em European Journal of Heart Failure, 2016.
  17. Adão, Rui. "Urocortin-2 attenuates right ventricular dysfunction in pulmonary arterial hypertension". Trabalho apresentado em European Journal of Heart Failure, 2016.
    Publicado
  18. Adão, Rui. "Neuregulin-1 improves right ventricular function and attenuates monocrotaline-induced pulmonary arterial hypertension". Trabalho apresentado em European Journal of Heart Failure, 2015.
    Publicado
  19. Adão, Rui. "Urocortin-2 improves right ventricular function in pulmonary arterial hypertension". Trabalho apresentado em European Journal of Heart Failure, 2015.
  20. Adão, Rui. "Urocortin-2 improves right ventricular function in pulmonary arterial hypertension". Trabalho apresentado em European heart journal, 2015.
    Publicado
  21. Adão, Rui. "The right ventricle molecular changes associated with pulmonary arterial hypertension are attenuated by neuregulin-1 treatment". Trabalho apresentado em European heart journal, 2014.
    Publicado
  22. Adão, Rui. "Molecular mechanisms underlying the beneficial effects of neuregulin-1 in pulmonary arterial hypertension". Trabalho apresentado em Cardiovascular Research Journal, 2014.
    Aceite para publicação
  23. Adão, Rui. "Neuregulin-1 preserves right ventricular diastolic function in animal model of pulmonary arterial hypertension". Trabalho apresentado em European heart journal, 2014.
    Publicado
  24. Adão, Rui. "Neuregulin-1 attenuates right ventricle hypertrophy in a model of pulmonary artery banding". Trabalho apresentado em European Journal of Heart Failure, 2014.
    Publicado
  25. Adão, Rui. "Urocortin-2 Improves Right Ventricular Function in Pulmonary Arterial Hypertension". Trabalho apresentado em Circulation, 2014.
    Publicado
  26. Adão, Rui. ". Neuregulin-1 ameliorates right ventricular diastolic dysfunction in pulmonary arterial hypertension". Trabalho apresentado em Cardiovascular Research, 2014.
    Publicado
  27. Adão, Rui; Kraler, Simon C; Holzer, Senka; Leite-Moreira, Adelino; Sedej, Simon; Brás-Silva, Carmen; ADELINO LEITE-MOREIRA. "Adão R, Mendes-Ferreira P, Hamdani N, Maia-Rocha C, Mendes MJ, Falcão-Pires I, De Keulenaer GW, Linke W, Leite-Moreira AF, Brás-Silva C. Neuregulin-1 preserves right ventricular diastolic function in animal model of pulmonary arterial hypertension. European Heart Journal". 2014.
  28. Adão, Rui. "Neuregulin-1 treatment reduces right ventricular dysfunction in pulmonary arterial hypertension". Trabalho apresentado em European Journal of Heart Failure, 2013.
  29. Adão, Rui. "Neuregulin-1 Chronic Treatment Improves Right Ventricle Cardiomyocyte Function in Pulmonary Hypertension". Trabalho apresentado em Circulation, 2013.
    Publicado
  30. Adão, Rui. "Neuregulin-1 modulates right ventricle cardiomyocyte function in pulmonary arterial hypertension". Trabalho apresentado em European heart journal, 2013.
    Publicado
  31. Adão, Rui. "Neuregulin attenuates pulmonary endothelial dysfunction in pulmonary hypertension". Trabalho apresentado em European heart journal, 2012.
    Publicado
  32. Adão, Rui. "Neuregulin attenuates right ventricular hypertrophy and dysfunction in an experimental model of pulmonary hypertension". Trabalho apresentado em Cardiovascular Research, 2012.
  33. Adão, Rui. "NRG1 improves right ventricular function in pulmonary hypertension". Trabalho apresentado em European heart journal, 2012.
  34. Adão, Rui. "Neuregulin Attenuates Right Ventricular and Pulmonary Endothelial Dysfunction in an Experimental Model of Pulmonary Hypertension". Trabalho apresentado em Circulation, 2012.
Tese / Dissertação
  1. Rui Miguel da Costa Adão. "Pathophysiological role of urocortin-2 System in pulmonary hypertension - therapeutic implications". Doutoramento, 2019. https://hdl.handle.net/10216/119067.
  2. Rui Miguel da Costa Adão. "Modulação da função ventricular direita pela neuregulina - 1 - implicações terapêuticas na hipertensão pulmonar". Mestrado, 2013. https://repositorio-aberto.up.pt/handle/10216/87920.

Outros

Outra produção
  1. Scientists on the Spot: Costantino Iadecola. 2025. Rui Adão; Costantino Iadecola. https://doi.org/10.1093/cvr/cvaf011.
    10.1093/cvr/cvaf011
Atividades

Apresentação oral de trabalho

Título da apresentação Nome do evento
Anfitrião (Local do evento)
2019 Invited Presentation - Are animal models in pulmonary arterial hypertension relevant to the clinical disease? Animal Models of Disease - 2nd Edition. Universidade de Aveiro, 6 Março 2019. Aveiro, Portugal.
2018 Invited Presentation - Presentation of the work “Pathophysiological role of urocortin-2 system in pulmonary hypertension – therapeutic implications” in National Science Summit 2018 (Lisbon Congress Center)

Organização de evento

Nome do evento
Tipo de evento (Tipo de participação) 		Instituição / Organização
2022/04 - Atual Ambassador of Frontiers in CardioVascular Biomedicine Congress (2022/04)
Conferência (Membro da Comissão Organizadora)
2013 - Atual Coordinator of the Project “Quando o coração falha: do laboratório à clínica” in School of Life and Health Sciences (every year) (2013) Universidade do Porto, Portugal
2012 - Atual Coordinator of the Project “Investigar com o Coração” in Junior University (every year) (2012)
Oficina (workshop)
 Universidade do Porto, Portugal

Participação em evento

Descrição da atividade
Tipo de evento 		Nome do evento
Instituição / Organização
2021/09 - Atual Rego B, Mendes-Ferreira P, Adão R, Maia-Rocha C, Santos-Gomes J, Vasconcelos I, Gandra I, Vaz-Salvador P, Leite-Moreira A, Brás-Silva C. The role of miR-146a in the pathophysiology of pulmonary arterial hypertension. Sixteenth - Young European Scientist – Meeting. Porto, Portugal
Congresso
2021/09 - Atual Vasconcelos I, Vaz-Salvador P, Adão R, Conceição G, Miranda-Silva D, Santos-Gomes J, Rego B, Maia-Rocha C, Mendes-Ferreira P, Leite-Moreira AF, Fontes-Sousa AP, Brás-Silva C. Pathophysiological and therapeutic implications of Urocortin-2 in Heart Failure with Preserved Ejection Fraction. YES meeting 16th edition – Young European Scientist Meeting. Porto, Portugal
Congresso
2021/02 - Atual Rego B, Mendes-Ferreira P, Adão R, Maia-Rocha C, Santos-Gomes J, Vasconcelos I, Gandra I, Vaz-Salvador P, Leite-Moreira A, Brás-Silva C. The role of miR-146a in the pathophysiology of pulmonary arterial hypertension. IJUP. 2021; Porto, Portugal.
Congresso
2021/02 - Atual Vasconcelos I, Adão R, Fontes-Sousa AP, Brás-Silva C. IJUP 14th edition. Ucns as biomarkers in cardiovascular disease. 2021; Porto, Portugal.
Congresso
2020 - Atual Adão R, Mendes-Ferreira P, Pinto AR, Leite-Moreira AF, Brás-Silva C. Urocortin-2 modulates altered myofilament calcium sensitivity in right heart failure induced by pulmonary arterial hypertension. Frontiers in CardioVascular Biomedicine Congress 2020. Virtual Congress
Congresso
2020 - Atual Adao R, Conceicao G, Miranda-Silva, Pimentel LD, Vaz-Salvador P, Maia-Rocha C, Mendes-Ferreira P, Lourenco AP, Falcao-Pires I, Leite-Moreira AF, Brás-Silva C. Role of urocortin-2 in heart failure with preserved ejection fraction. Congresso Português de Cardiologia 2020. Best Young Basic Researcher Session. Virtual Congress
Conferência
2019 - Atual Adão R, Kraler SC, Senka H, Leite-Moreira A, Sedej S, Brás-Silva C. Effects of urocortin-2 on cellular Ca2+ homeostasis in right heart failure induced by pulmonary artery hypertension. Congresso Português de Cardiologia 2019. Best Young Basic Researcher Session. Vilamoura
2018 - Atual Adão R, Kraler SC, Senka H, Leite-Moreira A, Sedej S, Brás-Silva C. Effects of urocortin-2 on cellular Ca2+ homeostasis in right heart failure induced by pulmonary artery hypertension. ERS (European Respiratory Society) International Congress 2018. Paris
2018 - Atual Pinto R, Maia-Rocha C, Adão R, Mendes-Ferreira P, Leite-Moreira AF, Brás-Silva C. Expression of GLUT1 and GLUT4 in right ventricle in Pulmonary Arterial Hypertension – Effects of chronic treatment with NRG1. IJUP’ 18 – 11th Meeting of Young Researchers of University of Porto. Porto, Portugal.
2018 - Atual Pintalhão M, Maia-Rocha C, Martins R, Adão R, Barros A, Leite-Moreira, Bettencourt P, Castro-Chaves P, Brás-Silva C. Serum Urocortin-2 is associated with Volume Overload and Pulmonary Hypertension in Acute Heart Failure. AHA (American Heart Association) Scientific Sessions 2018. Chicago, EUA.
2018 - Atual Mendes-Ferreira P, Adão R, Quarck R, Belge C, Delcroix M, BráS-Silva C. Activation of the Beta-3 adrenoceptor in experimental pulmonary hypertension Pulmonary hypertension. ERS (European Respiratory Society) International Congress 2018. Paris, França.
2018 - Atual Adão R, Mendes-Ferreira P, Santos-Ribeiro D, Maia-Rocha C, Pimentel L, Pinto C, Mulvaney EP, Reid HM, Kinsella BT, Potus F, Breuils-Bonnet S, Rademaker MT, Provencher S, Bonnet S, Leite-Moreira AF, Brás-Silva C. Urocortin-2 improves right ventricular function and attenuates pulmonary arterial hypertension. ERS (European Respiratory Society) International Congress 2018. Paris, França.
2018 - Atual Pinto AR, Maia-Rocha C, Adão R, Mendes-Ferreira P, Salgado S, Miranda I, Leite-Moreira AF, Brás-Silva C. Expression of Glycolysis genes in Pulmonary Arterial Hypertension – Effects of chronic treatment with NRG-1. 13th YES - Young European Scientist - Meeting – 2018. Porto, Portugal.
2018 - Atual Pimentel LD, Mendes- Ferreira P, Santos-Ribeiro D, Adão R, Maia-Rocha C, Monteiro- Pinto C, Provencher S, Bonnet S, Leite-Moreira AF, Brás-Silva C. MicroRNA-146a role in the pathophysiology of pulmonary arterial hypertension. 13th YES - Young European Scientist - Meeting – 2018. Porto, Portugal.
2018 - Atual Adão R, Pimentel LD, Mendes-Ferreira P, Maia-Rocha C, Monteiro-Pinto C, Leite-Moreira AF; Brás-Silva C. Urocortin-2 improves pulmonary endothelial function in experimental pulmonary arterial hypertension. Congresso Português de Cardiologia 2018; Albufeira, Portugal.
2018 - Atual Pinto AR, Maia-Rocha C, Adão R, Mendes-Ferreira P, Salgado S, Miranda I, Leite-Moreira AF, Brás-Silva C. Expression of GLUT1 and GLUT4 in right ventricle in Pulmonary Arterial Hypertension – Effects of chronic treatment with NRG1. VI AEICBAS Biomedical Congress. Porto, Portugal.
2017 - Atual Pimentel L, Mendes-Ferreira P, Maia-Rocha C, Adão R, Santos-Ribeiro D, Salgado S, Pinto C, Potus F, Provencher S, Bonnet S, Leite-Moreira AF, Brás-Silva C. O papel do MicroRNA-146a na hipertensão arterial pulmonar. Congresso Português de Cardiologia 2017. Albufeira, Portugal.
2017 - Atual Monteiro-Pinto C, Adão R, Mendes-Ferreira P, Maia-Rocha C, Santos-Ribeiro D, Pimentel LD, Leite-Moreira AF, Brás-Silva C. Urocortin-2 attenuates experimental pulmonary arterial hypertension and right ventricular dysfunction. IJUP’ 17 – 10th Meeting of Young Researchers of University of Porto. Porto, Portugal.
2017 - Atual Maia-Rocha C, Adão R, Mendes-Ferreira P, Leite-Moreira AF, Brás-Silva C. Expression of GLUT1 and GLUT4 in right ventricle in Pulmonary Arterial Hypertension – Effects of chronic treatment with NRG1. 9º Simpósio de Metabolismo. Porto, Portugal.
2017 - Atual Pinto C, Adão R, Mendes-Ferreira P, Maia-Rocha C, Santos-Ribeiro D, Pimentel L, Salgado S, Potus F, Rademaker MT, Bonnet S, Leite-Moreira AF, Brás-Silva C. Urocortin-2 improves right ventricular function and attenuates pulmonary arterial hypertension. Congresso Português de Cardiologia 2017. Albufeira, Portugal.
2017 - Atual Maia-Rocha C, Adão R, Mendes-Ferreira P, Salgado S, Leite-Moreira AF, Brás-Silva C. Efeito do tratamento crónico com neuregulina-1 na expressão génica dos transportadores da glucose na hipertensão arterial pulmonar. Congresso Português de Cardiologia 2017. Albufeira, Portugal.
2017 - Atual Salgado S, Adão R, Maia-Rocha C, Mendes-Ferreira P, Pinto C, Pimentel L, Falcão-Pires I, Leite-Moreira AF, Brás-Silva C. Modulação da função diastólica do ventrículo direito pela neuregulina-1 na hipertensão arterial pulmonar. Congresso Português de Cardiologia 2017. Albufeira, Portugal.
2016 - Atual Adão R, Mendes-Ferreira P, Maia-Rocha C, Santos-Ribeiro D, Pinto C, Pimentel L, Potus F, Breuils-Bonnet S, Rademaker M, Provencher S, Bonnet S, Leite-Moreira AF, Brás-Silva C. Urocortin-2 attenuates pulmonary arterial hypertension. 13th International Medical postgraduate conference – new frontiers in the research of Ph.D. students; Hradec Králové, República Checa.
2016 - Atual Pimentel LD, Mendes-Ferreira P, Potus F, Santos-Ribeiro D, Maia-Rocha C, Adão R, Monteiro-Pinto C, Leite-Moreira AF, Bonnet S, Brás-Silva C. MicroRNA-146a expression is increased in human PAH.Yes meeting 2016; Porto, Portugal.
2016 - Atual Mendes-Ferreira P, Potus F, Santos-Ribeiro D, Maia-Rocha C, Adão R, Leite-Moreira AF, Provencher S, Bonnet S, Brás-Silva C. MicroRNA-146a expression is increased in human PAH. Congresso Português de Cardiologia – CPC 2016. Vilamoura, Portugal.
2016 - Atual Mendes- Ferreira M, Adão R, Mendes-Ferreira P, Santos-Ribeiro D, Maia-Rocha C, Leite-Moreira AF, Brás-Silva C. Urocortin-2 Improves Right Ventricular Function in Pulmonary Arterial Hypertension. IJUP’16. Porto, Portugal.
2016 - Atual Adão R, Mendes-Ferreira P, Maia-Rocha C, Santos-Ribeiro D, Pinto C, Pimentel L, Potus F, Breuils-Bonnet S, Provencher S, Bonnet S, Leite-Moreira AF, Brás-Silva C. A urocortina-2 atenua a disfunção ventricular direita e a hipertensão arterial pulmonar. XXXII Congresso de Pneumologia; Algarve, Portugal.
2016 - Atual Mendes-Ferreira P, Santos-Ribeiro D, Maia-Rocha C, Adão R, Pimentel L, Pinto, C, Potus F, Leite-Moreira AF, Provencher S, Bonnet S, Brás-Silva C. O papel do MicroRNA-146a na hipertensão arterial pulmonar. XXXII Congresso de Pneumologia; Algarve, Portugal.
2016 - Atual Monteiro-Pinto C, Adão R, Mendes- Ferreira P, Maia-Rocha C, Santos-Ribeiro D, Pimentel LD, Leite-Moreira AF; Brás-Silva, C. Urocortin-2 improves right ventricular function and attenuates experimental pulmonary arterial hypertension. Yes meeting 2016; Porto, Portugal.
2016 - Atual Adão R, Mendes-Ferreira P, Maia-Rocha C, Santos-Ribeiro D, Potus F, Breuils-Bonnet S, Provencher S, Bonnet S, Rademaker MT, Leite-Moreira AF, Brás-Silva C. Urocortin-2treatment reduces right ventricular dysfunction in pulmonary arterial hypertension. ESC Congress 2016, Rome, Italy.
2016 - Atual Maia-Rocha C, Adao R, Mendes-Ferreira P, Santos-Ribeiro D, Rademaker M, Leite-Moreira AF, Brás-Silva C. The right ventricle molecular changes associated with pulmonary arterial hypertension are attenuated by Urocortin 2 Treatment. ESC Congress 2016; Rome, Italy.
2016 - Atual Adao R, Mendes-Ferreira P, Maia-Rocha C, Santos-Ribeiro D, Potus F, Breuils-Bonnet S, Provencher S, Bonnet S, Rademaker M, Leite-Moreira AF, Brás-Silva C. Urocortin-2 improves right ventricular function and attenuates experimental pulmonary arterial hypertension. Frontiers in CardioVascular Biology 2016; Florence, Italy
2016 - Atual Maia-Rocha C, Adao R, Mendes-Ferreira P, Santos-Ribeiro D, Rademaker M, Leite-Moreira AF, Brás-Silva C. Molecular Mechanisms underlying the beneficial effects of Urocortin 2 in pulmonary arterial hypertension. Frontiers in CardioVascular Biology 2016; Florence, Italy.
2016 - Atual Adão R, Mendes-Ferreira P, Maia-Rocha C, Santos-Ribeiro D, Potus F, Breuils-Bonnet S, Provencher S, Bonnet S, Leite-Moreira AF, Brás-Silva C. Urocortin-2 attenuates right ventricular dysfunction in pulmonary arterial hypertension. Heart Failure 2016 Conference. Florence, Italy.
2016 - Atual Maia-Rocha C, Adao R, Mendes-Ferreira P, Santos-Ribeiro D, Rademaker M, Leite-Moreira AF, Brás-Silva, C. The right ventricle molecular changes associated with pulmonary arterial hypertension are attenuated by Urocortin-2 treatment. Heart Failure 2016 Conference; Florence, Italy.
2016 - Atual Mendes-Ferreira P, Santos-Ribeiro D, Adao R, Maia-Rocha C, Mendes-Ferreira M, Sousa-Mendes C, Leite-Moreira AF, Brás-Silva C. Pulmonary artery banding-induced adaptive and maladaptive remodelling of the right ventricle in the rat. Heart Failure 2016 Conference; Florence, Italy.
2016 - Atual Adão R, Mendes-Ferreira P, Maia-Rocha C, Santos-Ribeiro D, Pinto C, Pimentel L, Potus F, Breuils-Bonnet S, Provencher S, Bonnet S, Leite-Moreira AF, Brás-Silva C. Urocortin-2 Improves Right Ventricular Function in Pulmonary Arterial Hypertension. American Thoracic Society 2016 International Conference; San Francisco, USA.
2016 - Atual Mendes-Ferreira P, Potus F, Santos-Ribeiro D, Maia-Rocha C, Adão R, Leite-Moreira AF, Provencher S, Bonnet S, Brás-Silva C. MicroRNA-146a Expression Is Increased in Human PAH. American Thoracic Society 2016 International Conference. San Francisco, USA.
2016 - Atual Maia-Rocha C, Adão R, Mendes-Ferreira P, Santos-Ribeiro D, Leite-Moreira AF, Brás-Silva C. Alterações moleculares subjacentes aos efeitos benéficos da urocortina2 na hipertensão arterial pulmonar. Congresso Português de Cardiologia – CPC 2016. Vilamoura, Portugal.
2016 - Atual Adão R, Mendes-Ferreira P, Maia-Rocha C, Santos-Ribeiro D, Potus F, Breuils-Bonnet S, Provencher S, Bonnet S, Leite-Moreira AF, Brás-Silva C. Urocortin-2 attenuates right ventricular dysfunction in pulmonary arterial hypertension. Congresso Português de Cardiologia – CPC 2016. Vilamoura, Portugal.
2016 - Atual Adão R, Santos-Ribeiro D, Mendes-Ferreira P, Maia-Rocha C, Rademaker M, Leite-Moreira AF, Brás-Silva C. Urocortin-2 improves right ventricular function in pulmonary and attenuates experimental pulmonar arterial hypertension. 5º Encontro de Doutorandos da Faculdade de Medicina da Universidade do Porto – 5º ED-FMUP. Porto, Portugal.
2015 - Atual Adão R, Santos- Ribeiro D, Mendes-Ferreira P, Maia-Rocha C, Alves BS, Leite-Moreira AF, Brás-Silva C. Urocortin2 improves right ventricular function in pulmonary arterial hypertension. European Congress of Cardiology. Londres. Reino Unido.
2015 - Atual Santos-Ribeiro D, Adão R, Mendes-Ferreira P, Maia-Rocia C, Alves BS, Leite-Moreira AF, Brás-Silva C. Urocortin-2 improves right ventricular function in pulmonary arterial hypertension. XXXVI Congresso Português de Cardiologia. Albufeira, Portugal.
2015 - Atual Santos-Ribeiro D, Mendes-Ferreira P, Adão R, Maia-Rocha C, Alves BS, Rademaker M, Leite-Moreira AF, Brás-Silva C. Urocortin-2 improves right ventricular function in pulmonary arterial hypertension. Heart Failure 2015. Sevilha, Spain.
2015 - Atual Mendes-Ferreira P, Adao R, Maia-Rocha C, Alves BS, Santos-Ribeiro D, Hamdani N, Linke WA, De Keulenaer GW, Leite-Moreira AF, Brás-Silva C. Neuregulin-1 improves right ventricular function and attenuates monocrotaline-induced pulmonary arterial hypertension. Heart Failure 2015. Sevilha, Spain.
2015 - Atual Mendes­-Ferreira P, Adão R, Maia-­Rocha C, Santos-­Ribeiro D, Alves BS, De Keulenaer GW, Leite ­Moreira AF, Brás­Silva C. Neuregulin­1 improves right ventricular function and attenuates monocrotaline­induced pulmonary arterial hypertension. Heart Failure Association Winter Research Meeting 2015. Les Diablerets, Switzerland
2015 - Atual Santos-­Ribeiro D, Mendes­-Ferreira P, Adão R, Maia-­Rocha C, Alves BS, Rademaker M, Leite Moreira AF, Brás ­Silva C. Urocortin­2 improves right ventricular function in pulmonary arterial hypertension. Heart Failure Association Winter Research Meeting 2015 January. Les Diablerets, Switzerland
2015 - Atual Adao R, Mendes-Ferreira P, Maia-Rocha C, Alves BS, Santos-Ribeiro D, Falcao-Pires I, De Keulenaer GW, Leite-Moreira AF, Bras-Silva C. A Neuregulina-1 modula a função dos cardiomiócitos do ventrículo direito na hipertensão arterial pulmonar. XXXV Congresso Português de Cardiologia, Albufeira, Portugal.
2014 - Atual Mendes-Ferreira P, Ribeiro D, Alves B, Adão R, Maia-Rocha C, de Keulenaer GW, Leite-Moreira AF, Brás-Silva C. Reversão da hipertrofia ventricular direita pela neuregulina-1. XXXV Congresso Português de Cardiologia
2014 - Atual Maia-Rocha C, Mendes-Ferreira P, Adão R, Santos-Ribeiro D, Alves BS, De Keulenaer GW, Leite-Moreira AF, Brás-Silva C. Molecular mechanisms underlying the beneficial effects of neuregulin-1 in pulmonary arterial hypertension. Frontiers in Cardiovascular Biology 2014. Barcelona, Spain.
2014 - Atual Adao R, Mendes-Ferreira P, Hamdani N, Maia-Rocha C, Mendes MJ, Falcao-Pires I, de Keulenaer GW, Linke W, Leite-Moreira AF, Bras-Silva C. Neuregulin-1 ameliorates right ventricular diastolic dysfunction in pulmonary arterial hypertension. Frontiers in Cardiovascular Biology 2014. Barcelona, Spain.
2014 - Atual Maia-Rocha C, Mendes-Ferreira P, Adao R, Santos-Ribeiro D, Alves BS,. De Keulenaer GW,. Leite-Moreira AF, Bras-Silva C. The right ventricle molecular changes associated with pulmonary arterial hypertension are attenuated by neuregulin-1 treatment. European Society of Cardiology Congress 2014. Barcelona, Spain.
2014 - Atual Adao R, Mendes-Ferreira P, Hamdani N, Maia-Rocha C, Mendes MJ, Falcao-Pires I, De Keulenaer GW, Linke W, Leite-Moreira AL, Bras-Silva C. Neuregulin-1 preserves right ventricular diastolic function in animal model of pulmonary arterial hypertension. European Society of Cardiology Congress 2014. Barcelona, Spain.
2014 - Atual Santos-Ribeiro D, Adão R, Maia-Rocha C, Alves B, Mendes-Ferreira P, Leite-Moreira AF, Brás-Silva C. Urocortin-2 Improves Right Ventricular Function In Pulmonary Arterial Hypertension. American Heart Association, Scientific Sessions 2014. Chicago, United States of America.
2014 - Atual Mendes-Ferreira P, Adão R, Maia-Rocha C, Santos-Ribeiro D, Alves BS, De Keulenaer GW, Leite-Moreira AF, Brás-Silva C. Neuregulin-1 improves right ventricular function and attenuates monocrotaline-induced pulmonary arterial hypertension. Heart Without Borders – Cardiovascular Development, Disease and Repair – International Conference. Porto, Portugal.
2014 - Atual Santos-Ribeiro D, Mendes-Ferreira P, Adão R, Maia-Rocha C, Alves BS, Leite-Moreira AF, Brás-Silva C. Urocortin-2 improves right ventricular function in pulmonar arterial hypertension. Heart Without Borders – Cardiovascular Development, Disease and Repair – International Conference 2014. Porto, Portugal.
2014 - Atual Alves BS, Santos-Ribeiro D, Adão R, Maia-Rocha C,Mendes-Ferreira P, Leite-Moreira A, Brás-Silva C. Modulation of right ventricle function by Neuregulin-1 therapeutic implications in pulmonary hypertension. IJUP’ 14 – 7th Meeting of Young Researchers of University of Porto, 2014, Porto, Portugal.
2014 - Atual Santos-Ribeiro D, Mendes-Ferreira P, Alves BS, Adão R, Maia-Rocha C, Leite-Moreira A, Brás-Silva C. Molecular mechanisms underlying the beneficial effect of Neuregulin-1 in the treatment of Pulmonary Arterial Hypertension. IJUP’ 14 – 7th Meeting of Young Researchers of University of Porto. 2014, Porto, Portugal.
2014 - Atual Mendes-Ferreira P, Santos-Ribeiro D, Alves BS, Adao R, Maia-Rocha C, Leite-Moreira AF, De Keulenaer GW, Bras-Silva C. Neuregulin-1 attenuates right ventricle hypertrophy in a model of pulmonary artery banding. Heart Failure Congress 2014, Athens, Greece.
2014 - Atual Adão R, Alves BS, Santos-Ribeiro D, Maia-Rocha C, Handani N, Mendes- Ferreira P, Falcão-Pires I., De Keulenaer GW, Linke W, Leite-Moreira AF, Brás-Silva C. Neuregulin-1 preserves right ventricular diastolic function in na animal modelo f pulmonar arterial hypertension. 9th YES - Young European Scientist - Meeting -2014. Porto, Portugal.
2013 - Atual Adão R, Meireles A, Mendes-Ferreira P, Maia-Rocha C, Falcão-Pires I, de Keulenaer GW, Leite-Moreira AF, Brás-Silva C. Neuregulin-1 decreases the passive force of cardiomyocytes from the right ventricle in pulmonary arterial hypertension. IJUP’ 13 – 6th meeting of young researchers at University of Porto. Porto, Portugal.
2013 - Atual Mendes-Ferreira P, Maia-Rocha C, Adão R, Cerqueira RJ, Mendes MJ, Lourenço AP, De Keulenaer GW, Leite-Moreira AF, Bras-Silva C. Neuregulin Attenuates Right Ventricular and Pulmonary Endothelial Dysfunction in an Experimental Model of Pulmonary Hypertension. World Symposium on Pulmonary Hypertension. Nice, France
2013 - Atual Mendes-Ferreira P, Adão R, Maia-Rocha C, Lourenco AP, Meireles A, Falcao-Pires I, de Keulenaer GW, Leite-Moreira AF, Bras-Silva C. Neuregulin-1 treatment reduces right ventricular dysfunction in pulmonary arterial Hypertension. Heart Failure 2013, Lisbon, Portugal.
2013 - Atual Adão R, Meireles A, Mendes-Ferreira P, Maia-Rocha C, Falcão-Pires , de Keulenaer G W,Leite-Moreira AF, Brás-Silva C. Neuregulin-1 modulates right ventricle cardiomyocyte function in pulmonary arterial hypertension. European Society of Cardiology Congress 2013. Amsterdam, Netherlands.
2013 - Atual Adão R, Meireles A, Mendes-Ferreira P, Maia-RochaC, Falcão-Pires I, de Keulenaer GW, Leite-Moreira AF and Brás-Silva C. Neuregulin-1 Chronic Treatment Improves Right Ventricle Cardiomyocyte Function in Pulmonary Hypertension. American Heart Association Scientific Sessions 2013. Dallas, USA
2013 - Atual Mendes-Ferreira P, Maia-Rocha C, Adão R, Lourenço A, Cerqueira R, Pinho S, Mendes M, Castro-Chaves P, de Keulenaer GW, Leite-Moreira AF, Brás-Silva C. Neuregulin-1 treatment reduces the severity of pulmonary arterial hypertension. IJUP’ 13- 6th Meeting of young researchers of University of Porto. Porto, Portugal.
2012 - Atual Adão R, Maia-Rocha C, Mendes-Ferreira P, Mendes MJ, Cerqueira RJ, Castro-Chaves P, De Keulenaer GW, Leite-Moreira AF, Brás-Silva C. Neuregulin attenuates pulmonary endothelial dysfunction in an experimental model of pulmonary hypertension. IJUP’12 – 5th meeting of young researchers at university of Porto. Porto, Portugal.
2012 - Atual Mendes-Ferreira P, Maia-Rocha C, Adão R, Lourenco AP, Cerqueira RJ, Mendes MJ, Castro-Chaves P, De Keulenaer GW, Leite-Moreira AF, Bras-Silva C. Neuregulin attenuates right ventricular hypertrophy and dysfunction in an experimental model of pulmonary hypertension. Frontiers in Cardio Vascular Biologia, 2nd Meeting. London.
2012 - Atual Mendes-Ferreira P, Maia-Rocha C, Adão R, Cerqueira RJ, Mendes MJ, Lourenço AP, Pinho S, De Keulenaer GW, Leite-Moreira A, Bras-Silva C. NRG-1 improves monocrotaline-induced right ventricular and pulmonary endothelial dysfunction. Heart Failure 2012. Belgrade, Serbia.
2012 - Atual Vidal-Meireles AM, Mendes-Ferreira P, Adão R, Maia-Rocha C, Cerqueira RJ, Mendes MJ, Castro-Chaves P, De Keulenaer GW, Leite-Moreira AF, Brás-Silva C. Neuregulin attenuates pulmonary endothelial dysfunction in pulmonary hypertension. 7th Yes Meeting 2012, Porto, Portugal.
2012 - Atual Mendes-Ferreira P, Maia-Rocha C, Adão R, Cerqueira RJ, Mendes MJ, Lourenço AP, De Keulenaer GW, Leite-Moreira AF, Bras-Silva C. Neuregulin Attenuates Right Ventricular and Pulmonary Endothelial Dysfunction in an Experimental Model of Pulmonary Hypertension. American Heart Association, Scientific Sessions 2012. Los Angeles, California, USA
2012 - Atual Mendes-Ferreira P, Maia-Rocha C, Adao R, Lourenço AP, Moura C, Mendes MJ, Pinho S, Areias JC, De Keulenaer GW, Leite-Moreira AF, Brás-Silva C. A neuregulina atenua a hipertrofia e a disfunção ventricular direitas num modelo experimental de hipertensão pulmonar. XXXIII Congresso Português de Cardiologia. Vilamoura, Portugal.
2012 - Atual Mendes-Ferreira P, Adao R, Cerqueira R, Maia-Rocha C, Mendes MJ, Castro-Chaves P, Leite-Moreira A, Brás-Silva C. A Neuregulina 1 atenua a disfunção endotelial na hipertensão arterial pulmonar. XXXIII Congresso Português de Cardiologia, Vilamoura, Portugal.
2012 - Atual Maia-Rocha C, Adao R, Mendes-Ferreira P, Mendes MJ, Pinho S. Lourenço AP, De Keulenaer GW, Leite-Moreira AF, Brás-Silva C. Neuregulin attenuates right ventricular hypertophy and dysfunction in a experimental model of pulmonar hypertension. IJUP’12 – 5th meeting of young researchers at university of Porto. Porto, Portugal.
2012 - Atual Mendes-Ferreira P, Maia-Rocha C, Adao R, Lourenco AP, Moura C, Pinho S, Areias JC, De Keulenaer GW, Leite-Moreira AF, Bras-Silva C. NRG-1 improves right ventricular function in pulmonary hypertension. European Congress of Cardiology. Munich. Germany
2012 - Atual Mendes-Ferreira P, Adao R, Maia-Rocha C, Cerqueira RJ, Mendes MJ, Castro-Chaves P, De Keulenaer GW, Leite-Moreira AF, Bras-Silva C. Neuregulin attenuates pulmonary endothelial dysfunction in pulmonary hypertension. European Congress of Cardiology. Munich. Germany.
2011 - Atual Mendes-Ferreira P, Maia-Rocha C, Adão R, Silva M, Lourenço AP, Leite-Moreira AF, Brás-Silva C. Neuregulin attenuates right ventricular hypertrophy and dysfunction in an experimental model of pulmonary hypertension. IJUP’ 11 – 4th meeting of young researchers at university of Porto. Porto, Portugal.
2011 - Atual Carmen Brás Silva, Ana Patrícia Fontes de Sousa, Mónica Almeida, Sónia Pinho, Cláudia Moura, Ana Pires, José Carlos Areias (Pedro Mendes Ferreira, Carolina Maia Rocha, Rui Adão, Maria Silva, Maria José Mendes, André Lourenço, Adelino Leite Moreira). Bolsa de Estudo João Porto - O papel do sistema da neuregulina na fisiopatologia da hipertensão pulmonar e na progressão para a insuficiência cardíaca. XXXII Congresso Português de Cardiologia. Lisbon, Portugal.
2011 - Atual Maia-Rocha C, Mendes-Ferreira P, Adão R, Lourenço AP, Leite-Moreira AF, Brás-Silva C. Neuregulin increased expression and its modulation by bosentan in pulmonary hypertension. IJUP’ 11 – 4th meeting of young researchers at university of Porto. Porto, Portugal.
2011 - Atual Brás-Silva C, Maia-Rocha C, Mendes-Ferreira P, Adão R, Lourenço AP, Leite-Moreira AF. Aumento da expressão génica de neuregulina e sua modulação pelo bosentan na hipertensão pulmonar. XXXII Congresso Português de Cardiologia. Lisboa, Portugal.
2011 - Atual Mendes-Ferreira P, Maia-Rocha C, Adão R, Silva M, Mendes MJ, Lourenço AP, Cerqueira RJ, Castro-Chaves P, De Keulenaer GW, Leite-Moreira AF, Brás-Silva C. Neuregulin attenuates right ventricular hypertrophy and dysfunction in an experimental model of pulmonary hypertension. Yes meeting´11 - 6th young european scientist meeting. Porto, Portugal.
2010 - Atual Comunicação oral efectuada no X Congresso de Geoquímica dos Países de Língua Portuguesa / XVI Semana de Geoquímica: Título - "Avaliação do risco potencial de exposição da população do Centro de Portugal ao chumbo ambiental, expresso nos solos da região" Autores - Adão, R.; Martins, H.; Patinha, C.; Reis, A.P.; C.Dias, A; Cachada A. P.;, Ferreira da Silva, E.; A. J. Sousa

Arbitragem científica em conferência

Nome da conferência Local da conferência
2021/08 - Atual Invited Chair for a session in European Society of Cardiology 2021 Congress
2020 - Atual Invited Chair for a session in Frontiers in CardioVascular Biomedicine 2020 Congress (FCVB)

Arbitragem científica em revista

Nome da revista (ISSN) Editora
2022/02/02 - Atual Frontiers of Cardiovascular Medicine
2021/02/03 - Atual Frontiers in Pharmacology FRONTIERS RESEARCH FOUNDATION
2020/06/03 - Atual Cardiovascular Research Oxford University Press
2020/04/01 - Atual Journal of Visualized Experiments MyJove Corp.
2020/03/03 - Atual Revista Portuguesa de Cardiologia (0870-2551) Elsevier

Curso / Disciplina lecionado

Disciplina Curso (Tipo) Instituição / Organização
2014 - Atual Teaching assistant in the Master Programme in Cardiovascular Pathophysiology and PhD programme in Cardiovascular Sciences at the Faculty of Medicine, University of Porto

Membro de associação

Nome da associação Tipo de participação
2015 - Atual Sociedade Portuguesa de Pneumologia
2014 - Atual European Society of Cardiology
2014 - Atual European Respiratory Society
2013 - Atual Sociedade Portuguesa de Cardiologia

Membro de comissão

Descrição da atividade
Tipo de participação 		Instituição / Organização
2020 - Atual Elected member of the Scientists of Tomorrow (SoT) Nucleus from European Society of Cardiology
2018 - Atual Member of the European Society of Cardiology (ESC) - working groups on Myocardial Function and Pulmonary Circulation & Right Ventricular Function Membership
2015 - 2015 Cardiology Basic Science Summer School-2015. Nice, France
Membro

Tutoria

Tópico Nome do aluno
2023 - Atual Supervisor of the thesis "Cardiovascular Effects of Relaxin-2: Therapeutic Potential and Future Perspectives"(Curricular Master Thesis - Medicine, Faculty of Medicine of University of Porto) Nísia Almeida Pinto
2021 - Atual Co-supervisor of the thesis "Role of Ucn2 in Heart Failure with Preserved Ejection Fraction" (PhD thesis in Cardiovascular Sciences - Faculty of Medicine of University of Porto) Inês Vasconcelos
2020 - Atual Co-supervisor of the thesis "Insight in the pathophysiological role of Mir-146a in Pulmonary Arterial hypertension - Therapeutic implications" (PhD thesis in Cardiovascular Sciences - Faculty of Medicine of University of Porto) Joana Gomes
2021 - 2022 Supervisor of the thesis "Pulmonary valve replacement: a new paradigm with tissue engineering"(Curricular Master Thesis - Medicine, Faculty of Medicine of University of Porto) Ruben Almeida Pinto
2020 - 2022 Co-supervisor of the thesis "Novel therapeutic approaches in Heart Failure with Preserved Ejection Fraction" (Curricular Master Thesis - Medicine, Faculty of Medicine of University of Porto) Pedro Vaz Salvador
2020 - 2022 Co-supervisor of the thesis "Does Urocortin-2 induce changes in neurogenesis and in the GABAergic system of the hippocampal formation of rats with HFpEF?" (Curricular Master Thesis - Medicine, Faculty of Medicine of University of Porto) Débora Costa
2020 - 2022 Co-supervisor of the thesis "Insight in the pathophysiological role of Mir-146a in Pulmonary Arterial hypertension" (Master thesis in Cardiovascular Pathophysiology - Faculty of Medicine of University of Porto) Beatriz Silva Rego
2020 - 2022 Co-supervisor of the thesis "Role of Ucn2 in Heart Failure with Preserved Ejection Fraction" (Master Thesis in Biochemistry - Institute of Biomedical Sciences Abel Salazar, University of Porto ) Inês Vasconcelos
2019 - 2020 Co-supervisor of the thesis; “Persistent Pulmonary Hypertension of the Newborn: Pathophysiological mechanisms and novel therapeutic approaches” (Curricular Master Thesis - Medicine, Faculty of Medicine of University of Porto) Sofia Martinho
2018 - 2020 Co-supervisor of the thesis "MicroRNAs as Prognostic Biomarkers in Heart Failure" (Master thesis in Cardiovascular Physiopathology - Faculty of Medicine of University of Porto) Ana Rita Figueiredo
2018 - 2019 Co-supervisor of the thesis; “Effects of Urocortin-2: Pathophysiological mechanisms and Therapeutic Potential” (Curricular Master Thesis - Medicine, Faculty of Medicine of University of Porto) Cláudia Monteiro Pinto
2017 - 2018 Co-supervisor of the Master thesis; “Neuregulin-1 effects in metabolic changes induced by Pulmonary Arterial Hypertension” (Master Degree in Molecular and Cellular Biology, University of Aveiro) Ana Rita Pinto
2017 - 2017 Co-supervisor of the Master thesis; “The role of Ucn-2 on doxorubicin-induced cardiomyopathy” (Master Degree in Drug Development, University of Antwerp). Raphaelle Corremans
2015 - 2016 Co-supervisor of the Master thesis; “Neuregulin-1 effects in metabolic changes induced by Pulmonary Arterial Hypertension” (Master Degree in Molecular and Cellular Biology, University of Aveiro) Stephanie Salgado
2013 - 2014 Co-supervisor of the Master thesis; “The role of urocortin-2 in Pulmonary Arterial Hypertension” (Master Degree in Molecular and Cellular Biology, University of Aveiro) Diana Santos Ribeiro
2012 - 2014 Co-supervisor of the Master thesis; “Modulation of right ventricle function by neuregulin-1” (Master Degree in Cardiovascular Pathophysiology, University of Porto) Bárbara Silva
2012 - 2013 Co-supervisor of the Master thesis: “ErbB receptor stimulation – a therapeutic approach in pulmonary hypertension” (Master Degree in Molecular Biotechnology, University of Porto) André Meireles
Distinções

Prémio

2020 Travel Grant for Frontiers in CardioVascular Biomedicine 2020 Congress (FCVB), Budapest- Title of abstract: "Urocortin-2 modulates altered myofilament calcium sensitivity in right heart failure induced by pulmonary arterial hypertension"
Société Européenne de Cardiologie, França
2020 Best Young Basic Researcher
Sociedade Portuguesa de Cardiologia, Portugal
2019 Merit Scholarship – Best student of Faculty of Medicine of University of Porto (2012/2013 school year)
Universidade do Porto, Portugal
2018 “Bolsa de Estudo João Porto” - Title: “Role of Urocortin-2 in Heart Failure with Preserved Ejection Fraction - pathophysiological and therapeutic implications”
Sociedade Portuguesa de Cardiologia, Portugal
2018 1º Award Thomé Villar/Boehringer Ingelheim, para o trabalho for the study: “Acute and chronic effects of urocortin-2 therapy on intracellular Ca2+ homeostasis in right heart failure induced by pulmonary arterial hypertension”
Sociedade Portuguesa de Pneumologia, Portugal
2018 Honorable mention – 2ª Edition of Janssen Inovation Award, ao trabalho "Urocortin-2 improves right ventricular function and attenuates pulmonary arterial hypertension"
2018 Travel Grant for ERS Congress 2018, Title of abstracts: "Urocortin-2 improves right ventricular function and attenuates pulmonary arterial hypertension " & "Role of Urocortin-2 in Ca2+ Handling Dysfunction in Right Ventricle Failure
European Respiratory Society, Suiça
2017 Servier award in Heart Failure – Basic Science - 2016/17- “Papel do MicroRNA-146a na hipertensão arterial pulmonar e na disfunção ventricular direita”
Sociedade Portuguesa de Cardiologia, Portugal
2017 European Respiratory Society - Short-Term Fellowship Grant ao estudo "Role of Urocortin-2 in Ca2+ Handling Dysfunction in Right Ventricle Failure Induced by Pulmonary Artery Hypertension"
European Respiratory Society, Suiça
2016 Thomé Villar/Boehringer Ingelheim Award - Title: “Urocortin-2 attenuates Pulmonary Arterial Hypertension"
Sociedade Portuguesa de Cardiologia, Portugal
2016 Robalo Cordeiro Award – SPP/Novartis - Title: “MicroRNA-146a is implicated in the development of Pulmonary Hypertension – Human and experimental insights"
Sociedade Portuguesa de Pneumologia, Portugal
2016 Physiology & Immunology Poster Presentation First Prize 11th YES - Young European Scientist Meeting - Title: “Urocortin-2 improves right ventricular function and attenuates pulmonary arterial hypertension”
Universidade do Porto, Portugal
2016 Travel Grant for European Society of Cardiology Congress, London- Title of abstract: "Urocortin-2 improves right ventricular function and attenuates pulmonary arterial hypertension"
2015 Travel Grant for ESC Congress 2015, London - Title of abstract: "Urocortin-2 improves right ventricular function and attenuates pulmonary arterial hypertension "
Société Européenne de Cardiologie, França
2015 1º Award Thomé Villar/Boehringer Ingelheim - Title: “Neuregulin-1 improves right ventricular function and attenuates experimental pulmonar arterial hypertension”
Sociedade Portuguesa de Pneumologia, Portugal
2015 Robalo Cordeiro Award – SPP/Novartis - Title: “Pathophysiological role of mir-146a in pulmonary arterial hypertension – therapeutic implications”
Sociedade Portuguesa de Pneumologia, Portugal
2015 Servier award in Heart Failure – Basic Science - Title: “A Urocortina-2 Atenua a Hipertensão Arterial Pulmonar e a Disfunção Ventricular Direita num Modelo Experimental de Hipertensão Pulmonar”
Sociedade Portuguesa de Cardiologia, Portugal
2015 Best communication 4th Doctoral Meeting – FMUP - Title: “Urocortin-2 improves right ventricular function in pulmonary arterial hypertension”
Universidade do Porto Faculdade de Medicina, Portugal
2014 Prof. Ernesto Morais Award/9th YES - Young European Scientist Meeting - Title: “Neuregulin-1 preserves right ventricular diastolic function in an animal model pulmonar arterial hypertension”
Universidade do Porto, Portugal
2014 Molecular mechanisms underlying the beneficial effects of neuregulin­ 1 in pulmonary arterial hypertension ­ Physiology & Immunology Poster Presentation First Prize
2014 “Bolsa de Estudo João Porto” - Title: "O papel do miRNA­146a na hipertensão arterial pulmonar" ­
Sociedade Portuguesa de Cardiologia, Portugal
2014 Servier award in Heart Failure – Basic Science - Title: “A neuregulina-1 atenua a hipertensão arterial pulmonar e a disfunção ventricular direita num modelo experimental de hipertensão pulmonar"
Sociedade Portuguesa de Cardiologia, Portugal
2005 Rotary Best Student Award - best student in Santa Maria da Feira (2003/2004 school year)